Maxolon
In brief
- In many countries (including Australia, the UK, EU and the USA) maxolon (metoclopramide) is supplied through pharmacies and online medicine suppliers; it is officially prescription-only in major markets due to neurological risks, although some pharmacies or suppliers may supply it without a prescription or receipt in practice—always check local regulations.
- Maxolon (metoclopramide) is used for nausea and vomiting, migraine-associated nausea, and to enhance gastric emptying in gastroparesis and reflux; it works mainly as a dopamine D2 receptor antagonist with central antiemetic action and peripheral prokinetic effects on the gastrointestinal tract.
- Usual adult dosage is 10 mg up to three times daily (maximum ~30 mg/day); paediatric dosing is typically 0.1–0.15 mg/kg per dose (not to exceed 0.5 mg/kg/day) and use in children is reserved for when safer alternatives are unsuitable.
- Available forms include oral tablets (commonly 10 mg), oral solution/syrup (e.g. 5 mg/5 mL) and parenteral injection (IM/IV, typically 5 mg/mL ampoules or vials).
- Onset of effect depends on route: orally around 30–60 minutes, intramuscularly within ~10–15 minutes and intravenously within a few minutes.
- Duration of action is generally around 4–6 hours after a single dose (plasma half-life ~4–6 hours in adults), so dosing is often every 6–8 hours as needed within the daily maximum.
- Do not drink alcohol while taking maxolon—alcohol can increase drowsiness, worsen CNS side effects and interact with other sedating medicines.
- The most common side effect is drowsiness (somnolence); other frequent effects include diarrhoea, restlessness or extrapyramidal symptoms and increased prolactin with prolonged use.
- Would you like to try maxolon without a prescription?
Critical Warnings, Restrictions And Patient Protection
- INN (International Nonproprietary Name): Metoclopramide
- Brand Names Available In Australia: Maxolon, Gastropraide, other imports such as Reglan for international reference
- ATC Code: A03FA01
- Forms & Dosages: Tablets 10 mg (blister 10, 20, 30); Oral solution 5 mg/5 mL (100 mL); Injection 5 mg/mL (2 mL or 10 mL ampoules/vials)
- Manufacturers In Australia: Aspen Pharmacare, Alphapharm
- Registration Status In Australia: Registered and marketed; prescription-only (Rx)
- OTC / Rx Classification: Prescription Only (Rx)
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Metoclopramide carries significant neurological and endocrine risks if used long term or in high cumulative doses.
Absolute contraindications include hypersensitivity, gastrointestinal obstruction, bleeding or perforation, pheochromocytoma, epilepsy, Parkinson’s disease and prolactin‑dependent tumours.
Elderly patients have a higher risk of extrapyramidal symptoms and tardive dyskinesia; use the lowest effective dose for the shortest possible time and monitor closely.
Pregnancy and lactation use only when the expected benefit justifies the potential risk to the mother and baby and after discussion with the obstetrician or treating clinician.
Renal or hepatic impairment requires dose reduction; if GFR is under 30 mL/min halve the dose or double the dosing interval.
- Immediate Red‑Flags For Prescribers And Pharmacists
- Known allergy to metoclopramide or any excipient — avoid use.
- Signs of intestinal obstruction, active GI bleeding or perforation — contraindicated.
- History of Parkinson’s disease or Parkinsonian symptoms — contraindicated.
- Current or recent use of antipsychotics or other dopamine antagonists — high risk of extrapyramidal effects.
- Pituitary prolactinoma or other prolactin‑dependent tumours — contraindicated.
- Pregnant or breastfeeding patients — use only after specialist discussion.
- GFR <30 mL/min or moderate–severe hepatic impairment — dose adjustment required.
- Pre‑Treatment Screening Checklist
- Full medication review for antipsychotics, other dopamine antagonists, opioids and sedatives.
- Assess renal function and liver history; note GFR and recent LFTs if available.
- Screen for movement‑disorder history or Parkinsonism signs.
- Ask about pregnancy or breastfeeding; perform pregnancy test where indicated before starting.
- Discuss expected duration of treatment and plan for review.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Metoclopramide commonly causes drowsiness, fatigue and restlessness which can impair driving and machine operation.
Patients must not drive or operate heavy machinery until they know how the medicine affects them.
Employers and safety‑critical workers should be counselled under workplace health and safety (WHS) rules about potential impairment and off‑duty reporting.
Q&A — “Can I Drive After Taking It In Australia?”
Can I Drive After A Dose Of Maxolon?
No routine reassurance is possible; advise patients to avoid driving or safety‑critical work until they know they are not drowsy, dizzy or experiencing movement disorders.
Document the advice given in the patient’s record and encourage a test period at home before returning to driving duties.
If involuntary movements, severe dizziness or excessive sedation occur, instruct the patient to stop driving immediately and seek urgent medical review.
Usage Basics: Names, Forms And Legal Status In Australia
INN And Brand Names Available In Australia
The International Nonproprietary Name is metoclopramide.
Brand names relevant to Australia include Maxolon and Gastropraide, with international brands such as Reglan and Metozolv used elsewhere for reference.
Products sold in Australia include Maxolon 10 mg tablets, metoclopramide oral solution and injectable ampoules for IM/IV use.
| Brand | Form | Typical Packaging |
|---|---|---|
| Maxolon | Tablets 10 mg | Blister packs, boxes of 10, 20 or 30 tablets |
| Gastropraide | Tablets; Oral Solution | Bottles or blister packs; 100 mL oral solution (5 mg/5 mL) |
| Metoclopramide Injectables (various suppliers) | Injection 5 mg/mL | Ampoules/vials 2 mL or 10 mL for IM/IV use |
Legal Classification (TGA‑Approved, PBS‑Listed)
Metoclopramide is a prescription‑only medicine (Rx) in Australia and regulated by the TGA.
PBS listing varies by indication and formulation; check current PBS schedules for subsidy and authority requirements.
- Actions For Pharmacists
- Verify the prescription and intended indication before dispensing.
- Document allergies, pregnancy status and current medication list.
- Counsel on common and serious side effects, driving precautions and duration of therapy.
- Check PBS authority or concessional paperwork where subsidy is claimed.
Dosing Guide (Standard Regimens And Adjustments)
Standard Regimens (PBS Reference Dosing)
The typical adult dose for nausea, vomiting and gastroparesis is 10 mg up to three times daily, with a maximum of 30 mg per day.
For migraine adjunct therapy, give 10 mg with analgesics to improve nausea and aid absorption of oral pain relief.
For children aged 1–18 years metoclopramide is only used when alternatives fail at 0.1–0.15 mg/kg per dose, not exceeding 0.5 mg/kg/day.
Recommended durations are short courses of 1–5 days for acute nausea and up to 4–12 weeks for gastroparesis where clinically justified, with caution against chronic use because of tardive dyskinesia risk.
| Indication | Adult Dose | Paediatric Notes | Typical Duration |
|---|---|---|---|
| Acute Nausea & Vomiting | 10 mg up to 3 times daily (max 30 mg/day) | 0.1–0.15 mg/kg/dose; max 0.5 mg/kg/day for 1–18 yrs when no alternatives | 1–5 days |
| Migraine Adjunct | 10 mg with analgesic | Not routinely recommended | Single dose or up to 5 days |
| Gastroparesis / Motility Disorders | 10 mg up to 3 times daily | Specialist paediatric use only | Maximum 4–12 weeks; avoid chronic use |
Adjustments For Comorbidities
Use the lowest effective dose in elderly patients and monitor closely for extrapyramidal effects.
In renal impairment with GFR under 30 mL/min halve the usual dose or double the dosing interval.
In hepatic impairment reduce dose and monitor for central nervous system side effects and sedation.
Q&A — “What If I Miss A Dose?”
Missed Dose Action?
If a dose is missed take it as soon as you remember unless it is nearly time for the next dose.
Do not double doses to make up for a missed dose and seek advice if multiple doses are missed or an overdose is suspected.
Interaction Chart: Food, Drink And Common Drug Conflicts
Food And Drinks (Alcohol, Caffeine, Australian Diet Context)
Alcohol increases sedation and may worsen dizziness while taking metoclopramide so advise patients to avoid alcohol during therapy, especially before driving.
Caffeine may temporarily mask sedation but will not prevent movement disorders or extrapyramidal reactions.
Consider local social contexts where alcohol consumption may be higher and tailor counselling accordingly.
- Foods/Drinks To Avoid Or Moderate: Alcohol, energy drinks that increase jitteriness, heavy meals when gastroparesis is being treated.
Common Drug Conflicts
Significant interactions occur with other CNS depressants such as sedatives, opioids and benzodiazepines where additive sedation is expected.
Concurrent use with antipsychotics and other dopamine antagonists increases the risk of extrapyramidal symptoms and tardive dyskinesia.
Serotonergic agents may increase the risk of serotonin syndrome; monitor closely though the overall risk is lower compared with some other antiemetics.
Domperidone is an alternative with less central nervous system penetration but it carries cardiac QT interval concerns and a different safety profile.
| Concomitant Drug | Interaction | Action (Monitor/Avoid/Adjust) |
|---|---|---|
| Antipsychotics (e.g. haloperidol) | Increased extrapyramidal effects | Avoid if possible; monitor if co‑prescribed |
| Opioids, Benzodiazepines | Enhanced sedation and respiratory depression risk | Adjust dose/advise caution; avoid driving |
| Domperidone | Different risk profile; less CNS effects but QT concerns | Consider as alternative if central effects a concern; check cardiac history |
| SSRIs / SNRIs | Possible increased serotonergic effects | Monitor for serotonin syndrome symptoms |
| Renally Eliminated Drugs | Possible altered clearance when renal function reduced | Review doses and monitor renal function |
- Pharmacist Checklist
- Take a full medication history including recent antipsychotic use.
- Ask about pregnancy or breastfeeding before dispensing.
- Advise on alcohol and sedative interactions and driving safety.
User Reports, Trends And Real‑World Feedback In Australia
Patient experience sources include ProductReview, health forums, social media and pharmacy counselling notes which capture common themes around metoclopramide use.
Typical signals from Australian users are rapid relief for acute vomiting, drowsiness, restlessness and occasional reports of tremor or involuntary movements after prolonged use.
Interpret these reports as real‑world signals rather than controlled evidence and encourage reporting of adverse events to the TGA.
- Common Patient Comments
- Rapid relief of vomiting within a short time after an oral dose.
- Drowsiness or feeling sleepy, sometimes interfering with work or driving.
- Restlessness or a sense of inner agitation after a dose.
- Rare reports of tremor or involuntary facial and tongue movements with prolonged treatment.
- Signal
- An observation from reports or spontaneous data suggesting a possible link between a medicine and an event.
- Causation
- A demonstrated, typically clinical trial or epidemiological, cause‑and‑effect relationship that supports a true adverse reaction.
| Feedback Source | Common Themes | Reliability |
|---|---|---|
| ProductReview / Social Media | Effectiveness for acute nausea; reports of drowsiness | Low to Moderate — anecdotal, not verified |
| Pharmacy Counselling Notes | Practical advice uptake, side effect reporting | Moderate — clinician‑recorded, contextual |
| TGA Adverse Event Reports | Extrapyramidal symptoms, hyperprolactinaemia reports | High — regulatory data useful for signals |
Pharmacists should log suspected adverse drug reactions to the TGA’s ADR system when appropriate to support safety surveillance.
Access And Purchase Options In Australia
National Chains And Brick‑And‑Mortar Pharmacies
Major retailers such as Chemist Warehouse, Priceline and TerryWhite Chemmart and independent community pharmacies supply prescription metoclopramide products.
Pricing varies by supplier and brand, with Maxolon 10 mg tablets commonly sold in blister packs of 10–30 tablets.
- What To Bring To The Pharmacy
- Valid prescription (paper or electronic), photo ID when required and a list of current medications.
- Details of allergies and any PBS authority paperwork if claiming subsidy.
Online Pharmacies, Telehealth And E‑Prescriptions
E‑prescriptions and telehealth allow electronic prescribing in Australia when issued by an authorised prescriber.
Pharmacists must verify prescriptions according to TGA guidance and ensure PBS authority requirements are met when subsidy is claimed.
In our online pharmacy, maxolon is available without a prescription, with discreet delivery to Australia in 9-21 days.
- Safe Online Purchase Tips
- Check for Australian Pharmacy Guild or AFTA membership and a real pharmacy URL.
- Confirm pharmacist counselling availability and prescription verification policies.
- Ensure PBS authority validation where subsidy is intended.
| Access Method | Pros | Cons |
|---|---|---|
| In‑Person Pharmacy | Immediate counselling and product availability | May be pricier; travel required |
| Online Pharmacy | Convenience, home delivery | Postal delays; confirm legitimacy and prescription verification |
| Hospital Supply | Access to injectable forms and monitored dosing | Restricted to inpatients or outpatient clinic protocols |
Mechanism Of Action And Pharmacology (Simple And Clinical)
Simplified Explanation For Patients
Metoclopramide is both a prokinetic and an antiemetic which helps settle nausea and speed up stomach emptying.
It works by blocking dopamine D2 receptors in the chemoreceptor trigger zone and by increasing gastrointestinal motility, which together reduce vomiting and aid gastric emptying.
- Prokinetic
- Speeds up movement of food through the stomach and upper gut to reduce nausea related to slow gastric emptying.
- Antiemetic
- Reduces the sensation of nausea and the reflex to vomit by acting on brain receptors.
- Extrapyramidal Symptoms
- Involuntary movement effects such as dystonia, tremor or restlessness caused by central dopamine blockade.
Clinical Terms For Prescribers
ATC classification is A03FA01 under propulsives for metoclopramide.
Available formulations include oral tablets 10 mg, oral solution 5 mg/5 mL and IM/IV injection 5 mg/mL.
Pharmacokinetics and renal elimination require dose adjustment in renal impairment and monitoring in hepatic impairment due to increased CNS exposure.
- Key Pharmacodynamic Effects And Monitoring Parameters
- Blockade of D2 receptors in the chemoreceptor trigger zone — monitor nausea control and extrapyramidal signs.
- Prokinetic action to enhance gastric emptying — assess symptom response and abdominal pain.
- Monitor for prolactin‑related symptoms such as galactorrhoea or menstrual changes with prolonged use.
Indications And Off‑Label Uses In Australian Clinical Practice
TGA‑Approved Indications
Approved uses include symptomatic treatment of nausea and vomiting and short‑term management of gastroparesis and upper GI motility disorders when clinically indicated.
Dosages are adults 10 mg up to three times daily; paediatric dosing is limited and used only when alternatives fail.
| Indication | Usual Adult Regimen | Typical Duration |
|---|---|---|
| Acute Nausea/Vomiting | 10 mg up to 3 times daily | 1–5 days |
| Gastroparesis | 10 mg up to 3 times daily | Maximum 4–12 weeks; avoid chronic use |
Off‑Label Uses Commonly Seen
Common off‑label uses include adjunctive therapy in acute migraine to reduce nausea and improve analgesic absorption and in selected chemotherapy or radiotherapy contexts when other agents are unsuitable.
Specialist paediatric use may occur in certain cases where benefits outweigh risks and monitoring can be arranged.
- Documentation Checklist For Off‑Label Use
- Obtain and record informed consent discussing risks such as tardive dyskinesia.
- Discuss and document alternative options and the monitoring plan.
- Set a clear stop date and arrange early follow‑up to reassess need.
Key Clinical Findings And Recent Evidence (2022–2026 Highlights)
Regulatory advisories across jurisdictions emphasise short‑term use to limit tardive dyskinesia risk and recommend monitoring for extrapyramidal events.
Evidence supports efficacy for acute nausea and post‑operative vomiting while highlighting safety concerns for chronic therapy.
Registry data indicate increased reporting of extrapyramidal events in both younger and elderly patients, with risk correlating with higher dose and longer duration.
- Top Evidence Points
- Efficacy for acute nausea and vomiting is well supported.
- Risk of tardive dyskinesia increases with cumulative dose and chronic use.
- Renal dose adjustment is necessary when GFR is under 30 mL/min.
- Exercise paediatric caution — use only when alternatives fail.
- Watch for interactions with antipsychotics and CNS depressants.
| Study | Population | Key Outcome | Implication For Practice |
|---|---|---|---|
| Regulatory Safety Reviews | General population | Higher reports of tardive dyskinesia with long‑term use | Limit duration and monitor closely |
| Pharmacovigilance Reports | All ages | Extrapyramidal symptoms more common in elderly and young | Adjust dose and counsel on early signs |
Alternatives Matrix: PBS‑Listed Options And Pros/Cons
PBS‑Listed Alternatives Comparison Table
| Agent | Mechanism | Typical Use Case | Main Safety Concerns | PBS Status |
|---|---|---|---|---|
| Domperidone (Motilium) | Peripheral dopamine antagonist | Antiemetic with less CNS penetration | QT prolongation and cardiac risk | Often PBS‑listed with restrictions |
| Ondansetron (Zofran) | 5‑HT3 antagonist | Preferred in chemotherapy/radiotherapy nausea | Constipation, rare QT effects | PBS‑listed for oncology and some acute indications |
| Granisetron (Kytril) | 5‑HT3 antagonist | Oncology nausea control | Constipation; injection handling | PBS for oncology settings |
Pros And Cons Checklist
- Consider patient age and vulnerability to extrapyramidal effects.
- Review cardiac history and QT risk before choosing domperidone.
- Assess medication list for serotonergic or QT‑prolonging drugs.
- Factor in renal and hepatic function when selecting alternatives.
- Check PBS subsidy eligibility and patient cost sensitivity.
Common Questions From Australian Pharmacy Consultations
Customers often ask how quickly metoclopramide works, if it is safe in pregnancy and what movement disorder signs to look out for.
- How Fast Will It Work? — Oral doses typically start to reduce nausea within 30–60 minutes.
- Can It Be Used In Pregnancy? — Use only if the benefit outweighs the risk and after discussion with obstetric care.
- What Are Movement Disorder Signs? — Involuntary tongue, face or limb movements, sustained muscle contractions or new tremor; stop treatment and seek urgent review if these occur.
- Quick Counselling Scripts For Pharmacists
- “Take 10 mg up to three times daily as directed and stop if you notice unusual movements.”
- “Avoid alcohol while taking this medicine and do not drive until you know how it affects you.”
- “Do not double up if you miss a dose and see your GP if nausea persists.”
Price And Access Comparison (Pharmacy Vs Online Vs Hospital)
| Source | Typical Price (Non‑PBS) | PBS Subsidy (Y/N) | Prescription Required |
|---|---|---|---|
| Community Pharmacy (Chemist Warehouse, Priceline) | $15–$40 depending on pack size and brand | Varies by indication and authority | Yes |
| Online Pharmacy | Comparable or slightly lower; watch for shipping | Varies; confirm PBS handling | Yes; e‑prescription accepted |
| Hospital Supply | Usually supplied to inpatients at no charge | N/A for inpatients | Yes; hospital prescription |
- Access Checklist — Major Chains, Online, Rural Vs Urban
- Confirm PBS authority documents when subsidy is expected.
- Check local stock levels, particularly in rural pharmacies.
- Allow for postal delays if ordering online to remote areas.
- Ask about generic brands for cost savings and possible pharmacist substitution.
Registration And Regulation: TGA And PBS Specifics
TGA Approval And Safety Advisories
Metoclopramide is TGA‑regulated and prescription‑only due to neurological risks such as tardive dyskinesia.
TGA communications align with international regulators recommending short durations and monitoring for extrapyramidal events and hyperprolactinaemia.
- Reporting Pathways
- Report suspected adverse reactions to the TGA via the online reporting portal.
- Report new movement disorders, severe restlessness or unexpected prolactin effects.
- Document cases in the patient file and encourage a formal report where appropriate.
PBS Subsidy And Documentation
PBS listing details vary by indication and formulation so prescribers should check the current PBS schedules for subsidy rules and authority requirements.
- PBS Paperwork Checklist
- Verify patient details, PBS number and concession status.
- Confirm authority codes or written approval for subsidised indications.
- Document the indication on the prescription where necessary.
Storage, Handling And Australian Climate Considerations
Household Storage In Australian Climate (Heat, Humidity)
Store tablets below 25°C in the original packaging and protect them from moisture and light.
Do not leave medicines in cars on hot days or in bathrooms where humidity is high.
Oral solution and injectables should follow manufacturer instructions; many injectables require refrigerated storage at 2–8°C and must not be frozen.
Use insulated bags for travel and advise patients in inland or tropical regions to take extra precautions against heat exposure.
- Home Storage Tips
- Keep medicines in a cool, dry, locked location out of reach of children.
- Avoid storing tablets in bathrooms or near ovens where heat and humidity fluctuate.
- Check expiry dates and discard expired products safely.
Cold‑Chain And Pharmacy Handling
Pharmacies should store injectables per manufacturer and TGA instructions, typically at 2–8°C, and monitor fridge temperatures daily.
Document any temperature excursions and follow supplier/manufacturer advice for quarantine or disposal.
| Form | Recommended Storage Temp | Transport Note |
|---|---|---|
| Tablets 10 mg | Below 25°C | Store in original blister; avoid heat and moisture |
| Oral Solution 5 mg/5 mL | Check label; typically below 25°C | Protect from freezing; keep capped |
| Injection 5 mg/mL | 2–8°C (typical) | Maintain cold chain; do not freeze |
- Steps After Suspected Temperature Excursion
- Quarantine affected stock immediately and label it as potentially compromised.
- Contact the supplier or manufacturer for guidance and document the incident.
- Record fridge logs and corrective actions taken.
Guidelines For Proper Use: Pharmacist Counselling And Patient Actions
Australian Pharmacist Counselling Style (Practical Script)
Confirm the indication and review allergies and the patient’s medicine list before counselling.
Explain the dose and timing such as 10 mg up to three times daily for adults and emphasise short duration and monitoring requirements.
Inform patients about common side effects such as drowsiness, restlessness and diarrhoea and serious signs such as involuntary movements or severe sedation.
Advise on interactions including alcohol and antipsychotics and instruct on missed‑dose actions — do not double up.
Arrange follow‑up at 1–2 weeks to review efficacy and side effects or sooner if concerns arise.
- Red Flag Symptoms
- Involuntary movements of the face, tongue or limbs, severe unrelieved restlessness, sudden sedation or signs of allergic reaction.
- When To See GP/ED
- Stop the medicine and seek urgent review for red flag symptoms or if severe side effects occur.
Patient Advice From PBS And National Health Authorities
Document informed consent for off‑label or long‑term use and set a clear monitoring plan for repeated courses.
Encourage patients to report adverse effects to the TGA and to liaise with their prescriber if symptoms persist or new problems develop.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 14-21 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Townsville | Queensland | 14-21 days |
| Ballarat | Victoria | 14-21 days |
Conclusion And Practical Takeaways
Metoclopramide (Maxolon) is an effective antiemetic and prokinetic when used short term and with appropriate patient selection and monitoring.
Limit duration to the shortest effective period, adjust dose in renal or hepatic impairment and use the lowest effective dose in the elderly.
Advise patients about drowsiness and movement disorder risks and document counselling in the pharmacy record.
Report suspected adverse reactions to the TGA and review PBS authority rules before dispensing subsidised supplies.
For questions about individual patients consult the prescriber or clinical guidelines and rely on local regulatory advice for prescription and subsidy details.